1. Cognitive impairment in heart failure: clinical implications, tools of assessment, and therapeutic considerations

   • Sotiria Liori
   • Angelos Arfaras-Melainis
   • John Parissis

   ReviewPaper 03 May 2021 Pages: 993 - 999

   

2. Social and environmental risks as contributors to the clinical course of heart failure

   • Koichi Narita
   • Eisuke Amiya

   ReviewPaper 04 May 2021 Pages: 1001 - 1016

   

3. Sedentary behavior and health outcomes in patients with heart failure: a systematic review and meta-analysis

   • Qiuge Zhao
   • Cancan Chen
   • Xiuzhen Fan

   ReviewPaper 22 June 2021 Pages: 1017 - 1028

   

4. Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials

   • Greta Ghizzardi
   • Cristina Arrigoni
   • Rosario Caruso

   ReviewPaper 17 April 2021 Pages: 1029 - 1041

   

5. Dependence and reduced motor function in heart failure: future directions for well-being

   • Hidetaka Hibino
   • Stacey L. Gorniak

   ReviewPaper 24 July 2021 Pages: 1043 - 1051

6. Minimally invasive versus conventional continuous-flow left ventricular assist device implantation for heart failure: a meta-analysis

   • Bufan Zhang
   • Shaohua Guo
   • Zhigang Liu

   ReviewPaper 03 April 2021 Pages: 1053 - 1061

   

7. Ventricular non-compaction review

   • Shaurya Srivastava
   • Majid Yavari
   • George Abela

   ReviewPaper 07 July 2021 Pages: 1063 - 1076

   

8. Right ventricular diastolic dysfunction and failure: a review

   • Youn-Hoa Jung
   • Xianfeng Ren
   • Wei Dong Gao

   ReviewPaper 19 May 2021 Pages: 1077 - 1090

   

9. Subclinical cardiac damage in cancer patients before chemotherapy

   • Iacopo Fabiani
   • Giorgia Panichella
   • Alberto Giannoni

   ReviewPaper Open access 27 July 2021 Pages: 1091 - 1104

   

10. Risk stratification in cardiogenic shock: a focus on the available evidence

    • C. Sciaccaluga
    • G. E. Mandoli
    • M. Cameli

    ReviewPaper Open access 14 July 2021 Pages: 1105 - 1117

    

11. Current and emerging drug targets in heart failure treatment

    • Nicolò Ghionzoli
    • Francesco Gentile
    • Giuseppe Vergaro

    ReviewPaper Open access 17 July 2021 Pages: 1119 - 1136

    

12. New antidiabetic therapy and HFpEF: light at the end of tunnel?

    • Marijana Tadic
    • Carla Sala
    • Cesare Cuspidi

    ReviewPaper Open access 11 April 2021 Pages: 1137 - 1146

13. Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?

    • Michele Correale
    • Renata Petroni
    • Savina Nodari

    ReviewPaper 07 June 2021 Pages: 1147 - 1163

14. The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction

    • Alberto Aimo
    • Vincenzo Castiglione
    • Michele Emdin

    ReviewPaper Open access 21 July 2021 Pages: 1165 - 1171

    

15. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments

    • Nicoletta Orphanou
    • Efstathios Papatheodorou
    • Aris Anastasakis

    ReviewPaper 14 July 2021 Pages: 1173 - 1191

    

16. Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?

    • Andrea Scotti
    • Andrea Munafò
    • Cosmo Godino

    ReviewPaper Open access 22 July 2021 Pages: 1193 - 1200

    

17. Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions

    • Grigorios Tsigkas
    • Anastasios Apostolos
    • Periklis Davlouros

    ReviewPaper 04 July 2021 Pages: 1201 - 1210

    

18. Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers

    • Kun Xiang
    • Muhammad Akram
    • Chengming Fan

    ReviewPaper 12 July 2021 Pages: 1211 - 1221

    

19. Diagnosis of cardiac sarcoidosis: a primer for non-imagers

    • Tanushree Agrawal
    • Yehia Saleh
    • Mouaz Al-Mallah

    ReviewPaper 29 June 2021 Pages: 1223 - 1233

    

20. The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences

    • C Sciaccaluga
    • N Ghionzoli
    • M Cameli

    ReviewPaper Open access 12 August 2021 Pages: 1235 - 1246

    

21. Speckle tracking echocardiography in primary mitral regurgitation: should we reconsider the time for intervention?

    • Maria Concetta Pastore
    • Giulia Elena Mandoli
    • Matteo Cameli

    ReviewPaper Open access 07 April 2021 Pages: 1247 - 1260

    

22. The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications

    • Dawud Abawi
    • Tommaso Rinaldi
    • Alessio Alogna

    ReviewPaper Open access 26 May 2021 Pages: 1261 - 1279

    

23. Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials

    • Alexander G. Hajduczok
    • Samer N. Muallem
    • John P. Boehmer

    ReviewPaper 24 September 2021 Pages: 1281 - 1300

    

24. Functional tricuspid regurgitation, related right heart remodeling, and available treatment options: good news for patients with heart failure?

    • Marijana Tadic
    • Cesare Cuspidi
    • Wolfang Rottbauer

    ReviewPaper Open access 15 July 2021 Pages: 1301 - 1312

    

25. Deciphering hypertrophic cardiomyopathy with electrocardiography

    • Thomas Gossios
    • Konstantinos Savvatis
    • Georgios K. Efthimiadis

    ReviewPaper 21 July 2021 Pages: 1313 - 1323

    

26. Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement

    • Michael Dandel

    ReviewPaper 17 April 2021 Pages: 1325 - 1339

    

27. Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020

    • Maya Guglin
    • Kareem Ballut
    • Roopa Rao

    ReviewPaper 02 July 2021 Pages: 1341 - 1353

    

28. Histamine receptors in heart failure

    • Scott P. Levick

    ReviewPaper 08 October 2021 Pages: 1355 - 1372

    

29. Filamin C in cardiomyopathy: from physiological roles to DNA variants

    • Shen Song
    • Anteng Shi
    • Yu Nie

    ReviewPaper 17 September 2021 Pages: 1373 - 1385

    

30. Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress

    • Aoxue Li
    • Ningning Zheng
    • Xudong Ding

    ReviewPaper Open access 05 May 2021 Pages: 1387 - 1394

    

31. Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases

    • Mieczysław Dutka
    • Rafał Bobiński
    • Karolina Zimmer

    ReviewPaper Open access 27 July 2021 Pages: 1395 - 1411

    

32. Multiple roles of cardiac macrophages in heart homeostasis and failure

    • Aneta Moskalik
    • Justyna Niderla-Bielińska
    • Anna Ratajska

    ReviewPaper Open access 13 August 2021 Pages: 1413 - 1430

    

33. New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy

    • Jingmin Yang
    • Yanying Chen
    • Danyan Xu

    ReviewPaper 28 August 2021 Pages: 1431 - 1441

    

34. A deep dive into the darning effects of biomaterials in infarct myocardium: current advances and future perspectives

    • Thiagarajan Hemalatha
    • Mayilvahanan Aarthy
    • Niraikulam Ayyadurai

    ReviewPaper 03 August 2021 Pages: 1443 - 1467

    

35. Response to letter to the editor regarding the article “SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis” Cardiac, renal protection with SGLT2 inhibitors is evident but not in every diabetic patient

    • Mahmoud Barbarawi
    • Owais Barbarawi
    • Kai Chen

    Letter 04 May 2021 Pages: 1469 - 1469